Amgen will buy Celgene's blockbuster psoriasis treatment Otezla for $13.4 billion in cash, according to The Wall Street Journal. 

Glenmark Pharmaceuticals is recalling 31,224 tubes of an antifungal cream due to customer complaints about its texture.

The University of Missouri-Kansas City has fired another professor from its pharmacy school after a faculty review, according to the Kansas City Star.

Ten hospitals and health systems posted job listings seeking pharmacy leaders in the last week.

Flint, Mich.-based Diplomat Pharmacy will pay $14.1 million to settle a class-action lawsuit that accused the company of misleading thousands of investors, according to MLive.com.

In response to the Ebola outbreak in the Democtratic Republic of Congo, HHS will fund the development of Merck's investigational Ebola vaccine.

An Oklahoma judge is expected to issue a ruling Aug. 26 on whether Johnson & Johnson is liable for fueling the state's opioid epidemic, according to CNBC.

President Donald Trump said he instructed the Department of Veterans Affairs to make a large purchase of Johnson & Johnson's Spravato, a controversial antidepressant approved this year by the FDA, according to the Military Times.

Drug giant Pfizer plans to invest $500 million to expand its manufacturing plant in Stanford, N.C., which focuses on gene therapy development, according to EndPoints News.

The former owner of St. Louis Hills Pharmacy was sentenced to two years in prison and ordered to pay $1.4 million for his role in a healthcare fraud scheme, the U.S. Justice Department said.